These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 28859268)
21. Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs. Lalsiamthara J; Senevirathne A; Lee JH Vaccine; 2019 Feb; 37(7):899-902. PubMed ID: 30661832 [TBL] [Abstract][Full Text] [Related]
22. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge. Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614 [TBL] [Abstract][Full Text] [Related]
23. The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle. Arenas-Gamboa AM; Ficht TA; Kahl-McDonagh MM; Gomez G; Rice-Ficht AC Infect Immun; 2009 Feb; 77(2):877-84. PubMed ID: 19047401 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Blasco JM; Gamazo C; Winter AJ; Jiménez de Bagüés MP; Marín C; Barberán M; Moriyón I; Alonso-Urmeneta B; Díaz R Vet Immunol Immunopathol; 1993 Aug; 37(3-4):257-70. PubMed ID: 8236802 [TBL] [Abstract][Full Text] [Related]
28. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798 [TBL] [Abstract][Full Text] [Related]
29. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369 [TBL] [Abstract][Full Text] [Related]
30. Brucella abortus S19 rfbD mutant is highly attenuated, DIVA enable and confers protection against virulent challenge in mice. Lalsiamthara J; Kaur G; Gogia N; Ali SA; Goswami TK; Chaudhuri P Biologicals; 2020 Jan; 63():62-67. PubMed ID: 31843357 [TBL] [Abstract][Full Text] [Related]
31. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model. Uslu A; Erganis O Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554 [TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. el Idrissi AH; Benkirane A; el Maadoudi M; Bouslikhane M; Berrada J; Zerouali A Rev Sci Tech; 2001 Dec; 20(3):741-7. PubMed ID: 11732416 [TBL] [Abstract][Full Text] [Related]
34. Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice. Magnani DM; Harms JS; Durward MA; Splitter GA Infect Immun; 2009 Nov; 77(11):5181-9. PubMed ID: 19703982 [TBL] [Abstract][Full Text] [Related]
35. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107 [TBL] [Abstract][Full Text] [Related]
36. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice. Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887 [TBL] [Abstract][Full Text] [Related]
37. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice. Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of Brucella abortus vaccine strain RB51 compared to the reference vaccine Brucella abortus strain 19 in water buffalo. Caporale V; Bonfini B; Di Giannatale E; Di Provvido A; Forcella S; Giovannini A; Tittarelli M; Scacchia M Vet Ital; 2010; 46(1):13-9, 5-11. PubMed ID: 20391363 [TBL] [Abstract][Full Text] [Related]
40. A potent Brucella abortus 2308 Δery live vaccine allows for the differentiation between natural and vaccinated infection. Zhang J; Yin S; Guo F; Meng R; Chen C; Zhang H; Li Z; Fu Q; Shi H; Hu S; Ni W; Li T; Zhang K J Microbiol; 2014 Aug; 52(8):681-8. PubMed ID: 24994009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]